WAVELIGHT ALLEGRETTO WAVE EXCIMER LASER SYSTEM

Excimer Laser System

FDA Premarket Approval P020050

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the wavelight allegretto wave excimer laser system. The device used optical zones of 6. 0 and 6. 5 mm with an ablation/treatment zone up to 9. 0 mm, and s indicated for laser assisted in situ keratomileusis (lasik): 1) for the reduction or elimination of myopia of up to -12. 0 diopters (d) of sphere and up to -6. 0 d of astigmatism at the spectacle plane; 2) in patients who are 18 years of age or older; and 3) in patients with documentation of a stable manifest refraction defined as

DeviceWAVELIGHT ALLEGRETTO WAVE EXCIMER LASER SYSTEM
Classification NameExcimer Laser System
Generic NameExcimer Laser System
ApplicantAlcon Laboratories, Inc.
Date Received2002-11-20
Decision Date2003-10-07
Notice Date2003-10-28
PMAP020050
SupplementS
Product CodeLZS
Docket Number03M-0491
Advisory CommitteeOphthalmic
Expedited ReviewNo
Combination Product No
Applicant Address Alcon Laboratories, Inc. 6201 South Freeway fort Worth, TX 76134-2099
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P020050Original Filing
S039 2021-09-02 Real-time Process
S038 2021-04-12 Real-time Process
S037 2021-01-19 Special (immediate Track)
S036 2020-12-04 30-day Notice
S035 2020-02-25 Normal 180 Day Track
S034 2019-09-16 Real-time Process
S033 2019-07-05 Real-time Process
S032 2019-02-21 Special (immediate Track)
S031 2018-09-26 30-day Notice
S030 2018-05-11 Real-time Process
S029 2018-02-27 Normal 180 Day Track
S028 2018-01-05 Real-time Process
S027 2017-09-28 Real-time Process
S026 2017-03-24 30-day Notice
S025
S024 2015-07-29 Real-time Process
S023 2015-07-20 Panel Track
S022 2015-04-09 30-day Notice
S021 2015-02-27 Real-time Process
S020 2015-02-11 Real-time Process
S019 2015-02-02 Normal 180 Day Track
S018 2014-10-23 Real-time Process
S017 2014-08-14 Normal 180 Day Track
S016 2014-01-29 30-day Notice
S015 2014-01-22 Real-time Process
S014 2013-07-22 Real-time Process
S013 2013-04-17 Special (immediate Track)
S012 2013-04-01 Panel Track
S011 2013-01-18 Real-time Process
S010 2012-11-05 Normal 180 Day Track
S009 2012-09-04 Normal 180 Day Track
S008 2012-07-30 Real-time Process
S007 2012-03-12 30-day Notice
S006 2011-04-04 Normal 180 Day Track
S005 2006-12-19 Normal 180 Day Track
S004 2006-01-30 Panel Track
S003 2005-04-01 Normal 180 Day Track
S002 2005-01-31 Real-time Process
S001 2004-05-21 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
00380659907944 P020050 000
00380659907463 P020050 006
00380659907678 P020050 009
00380659908170 P020050 014
00380659908163 P020050 014
00380659908965 P020050 015
00380650001108 P020050 015

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.